Design, synthesis and evaluation of new dihydropyrimidine derivatives as HBV capsid protein inhibitors.

Qiu X, Zhao S, Wang Y, Xiao K, Liu Y, Li Y, Wu S, Meng Q, Shan G

Open source

DOI
10.1016/j.bmc.2025.118320
Published
2025 Nov 1
Container
Bioorganic & medicinal chemistry
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.bmc.2025.118320,
  title = {Design, synthesis and evaluation of new dihydropyrimidine derivatives as HBV capsid protein inhibitors.},
  author = {Qiu X and Zhao S and Wang Y and Xiao K and Liu Y and Li Y and Wu S and Meng Q and Shan G},
  year = {2025},
  journal = {Bioorganic \& medicinal chemistry},
  doi = {10.1016/j.bmc.2025.118320},
  url = {https://doi.org/10.1016/j.bmc.2025.118320}
}

RIS

TY  - JOUR
TI  - Design, synthesis and evaluation of new dihydropyrimidine derivatives as HBV capsid protein inhibitors.
AU  - Qiu X
AU  - Zhao S
AU  - Wang Y
AU  - Xiao K
AU  - Liu Y
AU  - Li Y
AU  - Wu S
AU  - Meng Q
AU  - Shan G
PY  - 2025
JO  - Bioorganic & medicinal chemistry
DO  - 10.1016/j.bmc.2025.118320
UR  - https://doi.org/10.1016/j.bmc.2025.118320
ER  - 

APA

X, Q., S, Z., Y, W., K, X., Y, L., Y, L., S, W., Q, M., & G, S. (2025). Design, synthesis and evaluation of new dihydropyrimidine derivatives as HBV capsid protein inhibitors.. Bioorganic & medicinal chemistry. https://doi.org/10.1016/j.bmc.2025.118320

Source records